Cite

HARVARD Citation

    Zhang, Q. et al. (n.d.). 44PGlobal clinical trials validating bioequivalence with China-manufactured trastuzumab biosimilar, HLX02, and trastuzumab. Annals of oncology. p. . [Online]. 
  
Back to record